login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 



a b c d e f g h i j k l m n
o p q r s t u v w x y z


1 - 10 of 51   Items
Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Thursday, 12 Jun 2014
The results from a small, animal study challenge previously unsubstantiated published reports claiming that a five to 10mm “ice ball” margin beyond the tumour is necessary for effective cryoablation. Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation
MicroThermX microwave ablation system at CIRSE

MicroThermX microwave ablation system at CIRSE

Tuesday, 20 Sep 2011
The MicroThermX microwave ablation system (BSD Medical) was featured at BSD’s exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Munich, Germany, (10-14 September 2011). MicroThermX microwave ablation system at CIRSE
Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Monday, 19 Sep 2011
Overall hepatic response rate with chemosaturation treatment among patients was 70%. On the other hand, 30.4 months was the median overall survival in all patients. Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Hepatic chemosaturation—an emerging therapy in interventional oncology

Tuesday, 22 Feb 2011
Hepatic chemosaturation is a minimally invasive technique which delivers high doses of chemotherapy into the liver to more effectively battle tumours, while limiting toxicity to the rest of the body, making it safer than intrahepatic artery perfusion. Hepatic chemosaturation—an emerging therapy in interventional oncology

Radioembolisation prolongs life for inoperable HCC patients

Monday, 12 Jul 2010
More than three-fourths of hepatocellular carcinoma patients are not surgical candidates and radioembolisation with intra-arterial yttrium-90 extends patient survival. Radioembolisation prolongs life for inoperable HCC patients

Direct injection of gold nanoparticles into tumours could be a new treatment for pancreatic cancer

Monday, 12 Jul 2010
A radical new approach to the treatment of the disease, Reed A Omary claims. Direct injection of gold nanoparticles into tumours could be a new treatment for pancreatic cancer
North American Scientific signs definitive agreement

North American Scientific signs definitive agreement

Tuesday, 25 Sep 2007
Nomos Radiation Oncology business sold: September 2007 North American Scientific signs definitive agreement
CMS selected to provide treatment for New Proton Therapy Center

CMS selected to provide treatment for New Proton Therapy Center

Tuesday, 25 Sep 2007
CMS has been selected by ProCure Treatment Centers: September 2007 CMS selected to provide treatment for New Proton Therapy Center
Visualase announces successful treatment of brain metastases

Visualase announces successful treatment of brain metastases

Tuesday, 25 Sep 2007
completed treatment of the first six patients: September 2007 Visualase announces successful treatment of brain metastases
CMS collaborates with Still River Systems

CMS collaborates with Still River Systems

Tuesday, 25 Sep 2007
CMS to provide treatment planning support: September 2007 CMS collaborates with Still River Systems
Found: 51   Displaying: 1-10
Results: 1 2 3 4 5 Next Go to:

Related Section


Oncology Useful Links

Most popular


DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients
Friday, 29 Aug 2014
The multicentre, 800-patient study also demonstrated that directional atherectomy was non-inferior for treating peripheral arterial disease in patients with diabetes compared with those without ... DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients

First varicose vein patient treated with FDA-approved Varithena (polidocanol injectable foam) 1%
Tuesday, 12 Aug 2014
The first varicose vein patient has been treated with Varithena, the only FDA-approved foam for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities ... First varicose vein patient treated with FDA-approved Varithena (polidocanol injectable foam) 1%

Friday, 01 Aug 2014
ArtVentive has announced positive clinical results in conjunction with expanded enrolment in the ArtVentive Endoluminal Occlusion System (EOS device) OCCLUDE I post-market surveillance study. ArtVentive announces positive clinical results and expanded enrolment in OCCLUDE I post-market surveillance study

Features


The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Is all heat the same and does catheter design matter?
Wednesday, 13 Aug 2014
Mark S Whiteley writes that it is essential that every doctor practising varicose vein surgery has a good understanding of the principles of endovenous thermoablation. Is all heat the same and does catheter design matter?

Profiles


Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

James B Spies
Friday, 16 May 2014
The evolution of embolization over the past decade has been remarkable and it has fundamentally ... James B Spies

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions